Di halaman ini
01DGX harga
02Ringkasan
03Grafik
04Pemecahan saham
05Tentang
06Performa
07Valuasi & rasio
13Dividen
14Pendapatan
15Fundamental Lengkap
16Laporan
17Pemilik institusional (13F)
18Aktivis & pemilik 5%+
19Orang dalam perusahaan
20Kepemilikan ETF
21Konsensus
22Rekan
23Berita
25Sinyal Perdagangan
26Metrik Saya
DGX Quest Diagnostics Incorporated Common Stock
NYSE · Health Care · Lihat di SEC EDGAR ↗ 10-K/10-Q Okt 23, 2026
$241,89
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$171,18rendah 52m
$248,84tinggi 52m
Kapitalisasi Pasar (MRQ)
$26.61B
P/E (TTM)
24.1
EPS (TTM)
$10.04
Pendapatan (TTM)
$11.84B
lencana Anda
Rentang 52M
$171–$249
Peringkat Analis
HOLD
Target Harga
$255
P/E
24.1
ROE
15.2%
Margin Laba Bersih
9.5%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
DGX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$241.89
Kapitalisasi Pasar (MRQ)
$26.61B
P/E (TTM)
24.1
EPS (TTM)
$10.04
Pendapatan (TTM)
$11.84B
Imbal Hasil Dividen
1.3%
ROE (TTM)
15.2%
D/E Utang/Ekuitas (MRQ)
0.7
Rentang 52M
$171–$249
DGX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 21 Juni 2005 | 2-for-1 | Maju |
| 1 Juni 2001 | 2-for-1 | Maju |
Tentang Quest Diagnostics Incorporated Common Stock Tinjauan perusahaan dari Wikipedia
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019. The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing.
History
1960–1995
Originally founded as Metropolitan Pathology Laboratory, Inc. in 1967 by Paul A. Brown, MD, the clinical laboratory underwent a variety of name changes. In 1969, the company's name changed to MetPath, Inc. with headquarters in Teaneck, New Jersey. By 1982, MetPath was acquired by what was then known as Corning Glass Works and was subsequently renamed Corning Clinical Laboratories.
1996–2000
On December 31, 1996, Quest Diagnostics became an independent company as a spin-off from Corning. Kenneth W. Freeman was appointed as CEO during this transition. Over the next year, Quest acquired a clinical laboratory division of Branford, Connecticut–based Diagnostic Medical Laboratory, Inc. (DML). Two years later in 1999, Quest added SmithKline Beecham Clinical Laboratories to their subsidiaries; which includes a joint venture ownership with CompuNet Clinical Laboratory. The purchase of SmithKline Beecham also included the lab's medical sample transport airline (ICAO: LBQ, call sign: LABQUEST) originally founded in 1988.
In 1997, Quest and Banner Health formed a joint venture creating the Arizona based Sonora Quest laboratory, a business unit of Laboratory Sciences of Arizona. This entity represents the operations of Quest Diagnostics in the Arizona regional market.
2001–2015
From May 2004 to April 2012, Surya Mohapatra served as the company's President and CEO. In 2007 Quest acquired diagnostic testing equipment company AmeriPath. In response to Mohapatra's resignation after eight years with Quest, former Philips Healthcare CEO Stephen Rusckowski was appointed. Under Rusckowski, Quest Diagnostics teamed up with central New England's largest health care system, UMass Memorial Health Care, to purchase its clinical outreach laboratory.
2016–present
In 2016, Quest collaborated with Safeway to bring testing services to twelve of its stores in California, Maryland, Virginia, Texas and Colorado.
By the end of 2017, Quest, in partnership with Walmart, incorporated laboratory testing in about 15 of their locations in Texas and Florida.
In May 2018, the company announced it will become an in-network laboratory provider to UnitedHealthcare starting in 2019, providing access to 48 million plan members.
In September 2018, Quest moved its headquarters from Madison, where it was located since 2007, to Secaucus, New Jersey.
In November 2018, Quest launched QuestDirect, a consumer-initiated testing service that allows patients to order health and wellness lab testing from home.
In March 2020, the company launched a COVID-19 testing service. As of July 2020, Quest had performed more than 9.2 million COVID-19 molecular tests and 2.8 million serology tests.
In April 2024, Quest has added a new blood screening to their AD-Detect product line. This test will analyze the blood for a specific Alzheimer's protein, pTau-217.
In February 2025, Quest acquired select assets of Fresenius Medical Care's Spectra laboratories. Under a separate agreement, Quest now offers clinical testing and lab services related to dialysis and end-stage kidney disease.
Acquisitions
Partnerships
2005: Forms a strategic alliance with Ciphergen Biosystems to commercialize novel proteomic tests.
Controversies
Quest Diagnostics set a record in April 2009 when it paid $302 million to the government to settle a Medicare fraud case alleging the company sold faulty medical testing kits. It was the largest qui tam (whistleblower) settlement paid by a medical laboratory for manufacturing and distributing a faulty product. In May 2011, Quest paid $241 million to the state of California to settle a False Claims Act case that alleged the company had overcharged Medi-Cal, the state's Medicaid program, and provided illegal kickbacks as incentives for healthcare providers to use Quest labs.
In 2018, Quest Diagnostics was among a number of U.S.–based laboratories linked to inaccuracies of over 200 women's cervical smear tests for CervicalCheck, Ireland's national screening program. Audits of the testing performed by Quest (and another subcontractor, Clinical Pathology Laboratories, Inc. of Austin, Texas) showed a high rate of errors in analysis of samples which led to lawsuits and a government inquiry. Quest and the Irish government continue to settle the resulting lawsuits.
On June 3, 2019, Quest announced that American Medical Collection Agency (AMCA), a billing collections service provider, had informed Quest Diagnostics that an unauthorized user had access to AMCA’s system containing personal information AMCA received from various entities, including from Quest. AMCA provides billing collections services to Optum360, which in turn is a Quest contractor. AMCA later went bankrupt after the breach.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
sektorHealth Care
industriHealth Care
karyawan60.000
negaraUS
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$11.04B2016-12-31 → 2025-12-31
EPS$8.752016-12-31 → 2025-12-31
Arus Kas Bebas$1.36B2016-12-31 → 2025-12-31
Margin bersih9.5%2016-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | DGX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | 24.1rata-rata 5T ≈17.7 | ≈17.7 | 23.3 | Nilai wajar | |
| P/S (TTM) | 2.2rata-rata 5T ≈1.7 | ≈1.7 | 1.3 | Terlalu mahal | |
| P/B (MRQ) | 3.5rata-rata 5T ≈2.7 | ≈2.7 | 3.0 | Nilai wajar | |
| EV / EBITDA | 15.0rata-rata 5T ≈11.0 | ≈11.0 | 11.4 | Nilai wajar | |
| Harga / FCF (TTM) | 19.4rata-rata 5T ≈14.9 | ≈14.9 | · | · | |
| Harga / Arus Kas (TTM) | 13.6rata-rata 5T ≈10.8 | ≈10.8 | 9.8 | Nilai wajar | |
| EV / Revenue (EV / Pendapatan) | 2.9rata-rata 5T ≈2.2 | ≈2.2 | · | · | |
| EV / FCF | 23.4rata-rata 5T ≈18.8 | ≈18.8 | · | · | |
| Harga / Nilai Buku Berwujud (MRQ) | 4.4 | · | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | DGX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | 14.6%rata-rata 5T ≈15.6% | ≈15.6% | 8.3% | Tingkat teratas | |
| Margin EBITDA (TTM) | 19.5%rata-rata 5T ≈20.2% | ≈20.2% | 8.8% | Tingkat teratas | |
| Margin Sebelum Pajak (TTM) | 12.6%rata-rata 5T ≈14.5% | ≈14.5% | 3.8% | Tingkat teratas | |
| Margin Laba Bersih (TTM) | 9.5%rata-rata 5T ≈11.0% | ≈11.0% | 5.1% | Tingkat teratas | |
| ROA (TTM) | 6.8%rata-rata 5T ≈8.0% | ≈8.0% | 4.0% | Tingkat teratas | |
| ROE (TTM) | 15.2%rata-rata 5T ≈17.4% | ≈17.4% | 12.5% | Sejajar | |
| ROIC | 9.2%rata-rata 5T ≈11.0% | ≈11.0% | 9.2% | Sejajar |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | DGX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Utang / Ekuitas (MRQ) | 0.7rata-rata 5T ≈0.8 | ≈0.8 | 0.4 | Utang tinggi | |
| Rasio Lancar (MRQ) | 1.7rata-rata 5T ≈1.2 | ≈1.2 | 1.4 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 0.8rata-rata 5T ≈1.0 | ≈1.0 | 0.8 | Likuiditas kuat | |
| Utang Jangka Panjang / Ekuitas (MRQ) | 0.7rata-rata 5T ≈0.7 | ≈0.7 | 0.7 | Utang tinggi |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | DGX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 11.8%rata-rata 5T ≈3.6% | ≈3.6% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 3.7%rata-rata 5T ≈0.06% | ≈0.06% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 3.2% | · | · | · | |
| EPS YoY | 13.8%rata-rata 5T ≈2.0% | ≈2.0% | · | · | |
| Net Income YoY (Laba Bersih YoY) | 13.9%rata-rata 5T ≈-1.4% | ≈-1.4% | · | · | |
| EPS CAGR 3Y (CAGR EPS 3T) | 3.2%rata-rata 5T ≈-9.4% | ≈-9.4% | · | · | |
| EPS CAGR 5Y (CAGR EPS 5T) | -3.5% | · | · | · | |
| Net Income CAGR 3Y (CAGR Laba Bersih 3T) | 1.6%rata-rata 5T ≈-12.8% | ≈-12.8% | · | · | |
| Net Income CAGR 5Y (CAGR Laba Bersih 5T) | -7.1% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | DGX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.7rata-rata 5T ≈0.7 | ≈0.7 | 1.2 | Lemah | |
| Inventory Turnover (Perputaran Persediaan) | 39.1rata-rata 5T ≈33.9 | ≈33.9 | 15.6 | Tingkat teratas | |
| Receivables Turnover (Perputaran Piutang) | 8.1rata-rata 5T ≈7.7 | ≈7.7 | 10.5 | Lemah | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$183.9K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun
Imbal Hasil Dividen1.3%
Rasio Pembayaran Dividen35.6%
Pembayaran Tahunan≈$3.44
CAGR Dividen 5T≈7.4%
Rentetan Pertumbuhan≈14
| Tanggal ex-dividen | Jumlah | Mata Uang | Imbal Hasil |
|---|---|---|---|
| Okt 6, 2026 | $0,86 | USD | ≈1.5% |
| Jul 8, 2026 | $0,86 | USD | ≈1.6% |
| Apr 6, 2026 | $0,86 | USD | ≈1.6% |
| Jan 13, 2026 | $0,80 | USD | ≈1.8% |
| Okt 3, 2025 | $0,80 | USD | ≈1.8% |
| Jul 7, 2025 | $0,80 | USD | ≈1.8% |
| Apr 7, 2025 | $0,80 | USD | ≈1.9% |
| Jan 14, 2025 | $0,75 | USD | ≈2.0% |
| Okt 4, 2024 | $0,75 | USD | ≈2.0% |
| Jul 8, 2024 | $0,75 | USD | ≈2.1% |
| Apr 5, 2024 | $0,75 | USD | ≈2.2% |
| Jan 16, 2024 | $0,71 | USD | ≈2.1% |
| Okt 5, 2023 | $0,71 | USD | ≈2.3% |
| Jul 10, 2023 | $0,71 | USD | ≈2.0% |
| Apr 6, 2023 | $0,71 | USD | ≈1.9% |
| Jan 17, 2023 | $0,66 | USD | ≈1.8% |
| Okt 3, 2022 | $0,66 | USD | ≈2.1% |
| Jul 5, 2022 | $0,66 | USD | ≈1.9% |
| Apr 5, 2022 | $0,66 | USD | ≈1.9% |
| Jan 18, 2022 | $0,62 | USD | ≈1.8% |
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
3.6%
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Sep. 2026 | Okt 19, 2026 | $3.00 | $2.89 | 3.7% |
| 30 Juni 2026 | Jul 20, 2026 | $3.12 | $2.85 | 9.3% |
| 31 Maret 2026 | $2.50 | $2.37 | 5.5% | |
| 31 Des. 2025 | $2.42 | $2.38 | 1.5% | |
| 30 Sep. 2025 | $2.60 | $2.53 | 2.8% | |
| 30 Juni 2025 | $2.62 | $2.60 | 0.93% | |
| 31 Maret 2025 | $2.21 | $2.17 | 1.7% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B | $9.44B | $7.73B | $7.53B | $7.40B | $7.21B | $7.49B | $7.43B | |
| Cost of Revenue | $7.37B | $6.63B | $6.20B | $6.45B | $6.58B | $5.80B | $5.04B | $4.93B | $4.72B | $4.62B | $4.66B | $4.64B | |
| Gross Profit | · | · | · | · | · | $3.63B | $2.69B | $2.60B | $2.68B | $2.90B | $2.84B | $2.80B | |
| SG&A Expense | $1.97B | $1.77B | $1.64B | $1.87B | $1.73B | $1.55B | $1.46B | $1.42B | $1.44B | $1.38B | $1.68B | $1.73B | |
| Operating Expenses | $9.48B | $8.53B | $7.99B | $8.46B | $8.41B | $7.47B | $6.50B | $6.43B | $6.24B | $5.94B | $6.09B | $6.45B | |
| Operating Income | $1.56B | $1.35B | $1.26B | $1.43B | $2.38B | $1.97B | $1.23B | $1.10B | $1.17B | $1.28B | $1.40B | $983M | |
| Interest Expense | · | · | $163M | $148M | $152M | $166M | $180M | $169M | $153M | $144M | $154M | $167M | |
| Interest Income | $13M | $25M | $11M | $10M | $1M | $3M | $5M | $2M | $2M | $1M | $1M | $3M | |
| Other Non-op | $26M | $30M | $20M | $-55M | $369M | $76M | $20M | $-8M | $16M | $-48M | $-143M | $4M | |
| Pretax Income | $1.32B | $1.18B | $1.13B | $1.24B | $2.60B | $1.88B | $1.08B | $926M | $1.03B | $1.09B | $1.10B | $823M | |
| Income Tax | $314M | $273M | $248M | $264M | $597M | $460M | $247M | $182M | $241M | $429M | $373M | $262M | |
| Net Income | $992M | $871M | $854M | $946M | $2.00B | $1.43B | $858M | $736M | $772M | $645M | $709M | $556M | |
| EPS (Basic) | $8.87 | $7.78 | $7.59 | $8.10 | $15.85 | $10.62 | $6.36 | $5.39 | $5.63 | $4.58 | $4.92 | $3.83 | |
| EPS (Diluted) | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 | $10.47 | $6.28 | $5.29 | $5.50 | $4.51 | $4.87 | $3.81 | |
| Shares (Basic) | 111,000,000 | 111,000,000 | 112,000,000 | 116,000,000 | 125,000,000 | 134,000,000 | 134,000,000 | 136,000,000 | 137,000,000 | 140,000,000 | 144,000,000 | 145,000,000 | |
| Shares (Diluted) | 113,000,000 | 113,000,000 | 113,000,000 | 118,000,000 | 128,000,000 | 136,000,000 | 136,000,000 | 139,000,000 | 140,000,000 | 142,000,000 | 145,000,000 | 145,000,000 | |
| EBITDA | $2.13B | $1.84B | $1.70B | $1.86B | $2.79B | $2.33B | $1.56B | $1.41B | $1.44B | $1.53B | $1.70B | $1.30B |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $420M | $549M | $686M | $315M | $872M | $1.16B | $1.19B | $135M | $137M | $359M | $133M | $192M | |
| Receivables | $1.41B | $1.30B | $1.21B | $1.20B | $1.44B | $1.52B | $1.06B | $1.01B | $924M | $926M | $901M | $932M | |
| Inventory | $189M | $188M | $190M | $192M | $208M | $223M | $123M | $99M | $95M | $82M | $84M | $110M | |
| Prepaid Expense | $361M | $351M | $286M | $196M | $223M | $157M | $112M | $144M | $150M | $155M | $207M | $186M | |
| Current Assets | $2.38B | $2.39B | $2.37B | $1.90B | $2.74B | $3.06B | $2.49B | $1.39B | $1.31B | $1.53B | $1.50B | $1.60B | |
| PP&E (Net) | $2.20B | $2.11B | $1.82B | $1.77B | $1.71B | $1.63B | $1.45B | $1.29B | $1.15B | $1.03B | $925M | $933M | |
| PP&E (Gross) | $6.18B | $5.77B | $5.23B | $5.10B | $4.79B | $4.62B | $4.23B | $3.97B | $3.67B | $3.43B | $3.23B | $3.13B | |
| Accum. Depreciation | $3.97B | $3.66B | $3.42B | $3.34B | $3.09B | $2.99B | $2.78B | $2.68B | $2.53B | $2.40B | $2.31B | $2.19B | |
| Goodwill | $8.95B | $8.86B | $7.73B | $7.22B | $7.09B | $6.87B | $6.62B | $6.56B | $6.33B | $6.00B | $5.91B | $6.03B | |
| Intangibles | $1.64B | $1.76B | $1.17B | $1.09B | $1.17B | $1.17B | $1.12B | $1.21B | $1.12B | $949M | $984M | $1.07B | |
| Other Non-current Assets | $270M | $255M | $198M | $144M | $163M | $176M | $160M | $119M | $136M | $148M | $174M | $172M | |
| Total Assets | $16.23B | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B | $10.50B | $10.10B | $9.96B | $9.86B | |
| Accounts Payable | $1.60B | $1.39B | $1.36B | $1.40B | $1.60B | $1.63B | $1.04B | $1.02B | $1.02B | $975M | $1.01B | $1.19B | |
| Accrued Liabilities | $338M | $306M | $287M | $392M | $460M | $356M | $223M | $274M | $246M | $254M | $257M | $277M | |
| Current Liabilities | $2.28B | $2.17B | $1.81B | $1.55B | $1.75B | $1.78B | $1.99B | $1.49B | $1.06B | $981M | $1.17B | $1.71B | |
| Capital Leases | $537M | $535M | $503M | $489M | $494M | $499M | $413M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | $264M | $243M | $170M | $191M | $157M | $204M | |
| Other Non-current Liabilities | $957M | $938M | $876M | $812M | $792M | $847M | $711M | $745M | $663M | $654M | $514M | $594M | |
| Long-term Debt | $5.67B | $6.22B | $4.71B | $3.98B | $4.01B | $4.01B | $4.77B | $3.89B | $3.78B | $3.73B | $3.65B | $3.74B | |
| Total Debt | $5.67B | $6.22B | $4.71B | $3.98B | $4.01B | $4.01B | $4.77B | $3.89B | $3.78B | $3.73B | $3.65B | $3.76B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Retained Earnings | $9.99B | $9.36B | $8.82B | $8.29B | $7.65B | $9.30B | $8.17B | $7.60B | $7.14B | $6.61B | $6.20B | $5.72B | |
| Treasury Stock | $5.18B | $4.86B | $4.83B | $4.67B | $3.45B | $5.37B | $5.22B | $5.00B | $4.78B | $4.46B | $3.96B | $3.81B | |
| AOCI | $-27M | $-88M | $-14M | $-21M | $-14M | $-21M | $-39M | $-59M | $-48M | $-72M | $-38M | $-27M | |
| Stockholders' Equity | $7.17B | $6.78B | $6.31B | $5.89B | $6.44B | $6.76B | $5.64B | $5.22B | $4.92B | $4.63B | $4.68B | $4.30B | |
| Liabilities + Equity | $16.23B | $16.15B | $14.02B | $12.84B | $13.61B | $14.03B | $12.84B | $11.00B | $10.50B | $10.10B | $9.96B | $9.86B | |
| Shares Outstanding | 110,000,000 | 111,000,000 | 111,000,000 | 111,000,000 | 119,000,000 | 133,000,000 | 133,000,000 | 135,000,000 | 135,000,000 | 137,000,000 | 143,000,000 | 144,000,000 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $570M | $493M | $439M | $437M | $408M | $361M | $329M | $309M | $270M | $249M | $304M | $314M | |
| Stock-based Comp | $88M | $88M | $77M | $77M | $79M | $97M | $56M | $61M | $79M | $69M | $52M | $51M | |
| Deferred Tax | $105M | $13M | $-49M | $1M | $-57M | $85M | $15M | $73M | $9M | $37M | $112M | $23M | |
| Amort. of Intangibles | $154M | $127M | $108M | $120M | $103M | $103M | $96M | $90M | $74M | $72M | $81M | $94M | |
| Restructuring | · | · | · | $55M | $13M | $14M | $-3M | $49M | $30M | $11M | $39M | $43M | |
| Other Non-cash | $131M | $-131M | $-49M | $257M | $-192M | $31M | $-15M | $21M | $45M | $69M | $-367M | $-6M | |
| Operating Cash Flow | $1.89B | $1.33B | $1.27B | $1.72B | $2.23B | $2.00B | $1.24B | $1.20B | $1.18B | $1.12B | $821M | $944M | |
| CapEx | $527M | $425M | $408M | $404M | $403M | $418M | $400M | $383M | $252M | $293M | $263M | $308M | |
| Investing Cash Flow | $-631M | $-2.55B | $-1.06B | $-543M | $21M | $-772M | $-411M | $-801M | $-830M | $-127M | $-362M | $-1.02B | |
| Stock Repurchased | $450M | $151M | $275M | $1.41B | $2.20B | $325M | $353M | $322M | $465M | $590M | $224M | $132M | |
| Net Stock Activity | $-450M | $-151M | $-275M | $-1.41B | $-2.20B | $-325M | $-353M | $-322M | $-465M | $-590M | $-224M | $-132M | |
| Dividends Paid | $353M | $331M | $314M | $305M | $309M | $297M | $286M | $266M | $247M | $223M | $212M | $187M | |
| Financing Cash Flow | $-1.39B | $1.08B | $160M | $-1.73B | $-2.54B | $-1.27B | $225M | $-401M | $-592M | $-738M | $-518M | $86M | |
| Net Change in Cash | $-129M | $-137M | $371M | $-557M | $-286M | · | · | · | $-222M | $226M | $-59M | $5M | |
| Taxes Paid | $169M | $256M | $317M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.36B | $909M | $864M | $1.31B | $1.83B | $1.59B | $843M | $817M | $923M | $776M | $547M | $630M | |
| Levered FCF | · | · | $737M | $1.20B | $1.71B | $1.46B | $704M | $681M | $806M | $689M | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 38.5% | 34.8% | 34.6% | 38.8% | 38.6% | 37.9% | 37.6% | |
| Operating Margin | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% | 20.9% | 15.9% | 14.6% | 15.1% | 17.0% | 18.7% | 13.2% | |
| Net Margin | 9.0% | 8.8% | 9.2% | 9.6% | 18.5% | 15.2% | 11.1% | 9.8% | 10.0% | 8.6% | 9.5% | 7.5% | |
| Pretax Margin | 11.9% | 11.9% | 12.2% | 12.5% | 24.1% | 20.0% | 13.9% | 12.3% | 13.4% | 14.4% | 14.7% | · | |
| EBITDA Margin | 19.3% | 18.6% | 18.4% | 18.9% | 25.9% | 24.7% | 20.2% | 18.7% | 18.6% | 20.3% | 22.7% | 17.4% | |
| ROA | 6.1% | 5.8% | 6.4% | 7.1% | 14.4% | 10.7% | 7.2% | 6.8% | 7.5% | 6.4% | 7.1% | 5.9% | |
| ROE | 14.2% | 13.3% | 14.0% | 15.3% | 30.2% | 23.1% | 15.8% | 14.5% | 16.2% | 13.9% | 15.8% | 13.5% | |
| ROIC | 9.2% | 8.0% | 8.9% | 11.4% | 17.5% | 13.8% | 9.1% | 9.7% | 10.2% | 9.2% | 11.1% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.1 | 1.3 | 1.2 | 1.6 | 1.7 | 1.3 | 0.9 | 1.2 | 1.6 | 1.3 | 0.9 | |
| Quick Ratio | 0.8 | 0.9 | 1.0 | 1.0 | 1.3 | 1.5 | 1.1 | 0.8 | 1.0 | 1.3 | 0.9 | 0.7 | |
| Debt / Equity | 0.8 | 0.9 | 0.7 | 0.7 | 0.6 | 0.6 | 0.8 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | |
| LT Debt / Equity | 0.7 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.8 | 0.8 | 0.7 | 0.8 | |
| Interest Coverage | · | · | 7.7 | 9.6 | 15.7 | 11.9 | 6.8 | 6.5 | 7.6 | 8.9 | · | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | |
| Inventory Turnover | 39.1 | 35.1 | 32.5 | 32.2 | 30.5 | 33.5 | 45.4 | 50.8 | 53.3 | 55.6 | 48.0 | 46.1 | |
| Receivables Turnover | 8.1 | 7.9 | 7.7 | 7.5 | 7.3 | 7.3 | 7.4 | 7.8 | 8.3 | 8.2 | 8.2 | 8.3 |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $65.18 | $61.06 | $56.82 | $53.09 | $54.15 | $50.82 | $42.41 | $38.64 | $36.45 | $33.78 | $32.76 | $29.87 | |
| Revenue / Share | $97.65 | $87.36 | $81.88 | $83.75 | $84.28 | $69.39 | $56.81 | $54.18 | $55.06 | $52.92 | $51.68 | $51.28 | |
| Cash Flow / Share | $16.69 | $11.81 | $11.26 | $14.56 | $17.45 | $14.74 | $9.14 | $8.63 | $8.39 | $7.53 | $5.59 | $6.47 | |
| Cash / Share | $3.82 | $4.95 | $6.18 | $2.84 | $7.33 | $8.71 | $8.96 | $1.00 | $1.01 | $2.62 | $0.93 | $1.33 | |
| Dividend / Share | · | · | · | · | · | · | · | · | $1.80 | $1.65 | $1.52 | $1.32 | |
| EPS (TTM) | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 | $10.47 | $6.28 | $5.29 | $5.50 | $4.51 | $4.87 | $3.81 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 6.7% | -6.4% | -8.4% | 14.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 3.7% | -2.9% | -0.66% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 13.8% | 2.7% | -6.0% | -48.8% | 48.5% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 3.2% | -20.9% | -10.6% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 13.9% | 2.0% | -9.7% | -52.6% | 39.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 1.6% | -24.1% | -15.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -7.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 3.5% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B | $9.44B | $7.73B | $7.53B | $7.40B | $7.21B | $7.49B | $7.43B | |
| Net Income TTM | $992M | $871M | $854M | $946M | $2.00B | $1.43B | $858M | $736M | $772M | $645M | $709M | $556M | |
| Market Cap | $19.09B | $16.75B | $15.30B | $17.36B | $20.59B | $15.85B | $14.20B | $11.24B | $13.30B | $12.59B | $10.17B | $9.66B | |
| Enterprise Value | $24.34B | $22.41B | $19.33B | $21.03B | $23.73B | $18.71B | $17.78B | $15.00B | $16.94B | $15.97B | $13.69B | $13.23B | |
| P/E | 19.8 | 19.6 | 18.4 | 19.6 | 11.1 | 11.4 | 17.0 | 15.7 | 17.9 | 20.4 | 14.6 | 17.6 | |
| P/S | 1.7 | 1.7 | 1.7 | 1.8 | 1.9 | 1.7 | 1.8 | 1.5 | 1.8 | 1.7 | 1.4 | 1.3 | |
| P/B | 2.7 | 2.5 | 2.4 | 2.9 | 3.2 | 2.3 | 2.5 | 2.2 | 2.7 | 2.7 | 2.2 | 2.2 | |
| P / Cash Flow | 10.1 | 12.6 | 12.0 | 10.1 | 9.2 | 7.9 | 11.4 | 9.4 | 11.3 | 11.8 | 12.6 | 10.3 | |
| P / FCF | 14.0 | 18.4 | 17.7 | 13.2 | 11.3 | 10.0 | 16.8 | 13.8 | 14.4 | 16.2 | 18.6 | 15.3 | |
| EV / EBITDA | 11.4 | 12.2 | 11.4 | 11.3 | 8.5 | 8.0 | 11.4 | 10.6 | 11.8 | 10.5 | 8.0 | 10.2 | |
| EV / FCF | 17.9 | 24.7 | 22.4 | 16.0 | 13.0 | 11.8 | 21.1 | 18.4 | 18.4 | 20.6 | 25.0 | 21.0 | |
| EV / Revenue | 2.2 | 2.3 | 2.1 | 2.1 | 2.2 | 2.0 | 2.3 | 2.0 | 2.3 | 2.2 | 1.8 | 1.8 | |
| Dividend Yield | 1.8% | 2.0% | 2.1% | 1.8% | 1.5% | 1.9% | 2.0% | 2.4% | 1.9% | 1.8% | 2.1% | 1.9% | |
| Earnings Yield | 5.0% | 5.1% | 5.4% | 5.1% | 9.0% | 8.8% | 5.9% | 6.3% | 5.6% | 4.9% | 6.9% | 5.7% | |
| Payout Ratio | 35.6% | 38.0% | 36.8% | 32.2% | 15.5% | 20.8% | 33.3% | 36.1% | 32.0% | 34.6% | 29.9% | 33.6% | |
| Annual Payout | $353M | $331M | $314M | $305M | $309M | $297M | $286M | $266M | $247M | $223M | $212M | $187M |
Laporan Laba Rugi
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.10B | $3.04B | $2.90B | $2.81B | $2.82B | $2.76B | $2.65B | $2.62B | $2.49B | $2.40B | $2.37B | $2.29B | $2.29B | $2.34B | $2.33B | $2.33B | |
| Cost of Revenue | $2.06B | $2.02B | $1.95B | $1.90B | $1.87B | $1.82B | $1.79B | $1.76B | $1.68B | $1.59B | $1.59B | $1.55B | $1.54B | $1.55B | $1.56B | $1.57B | |
| SG&A Expense | $523M | $529M | $504M | $504M | $501M | $486M | $476M | $466M | $448M | $416M | $440M | $407M | $380M | $416M | $439M | $563M | |
| Operating Expenses | $2.62B | $2.58B | $2.50B | $2.42B | $2.43B | $2.32B | $2.31B | $2.26B | $2.16B | $2.04B | $2.07B | $2.02B | $1.95B | $1.99B | $2.03B | $2.20B | |
| Operating Income | $479M | $459M | $399M | $386M | $386M | $438M | $346M | $361M | $330M | $355M | $300M | $267M | $342M | $348M | $305M | $135M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $47M | $49M | · | $41M | $39M | $37M | · | |
| Interest Income | $6M | $5M | $2M | $3M | $3M | $2M | $5M | $7M | $9M | $3M | $6M | $6M | $1M | $2M | $2M | $4M | |
| Other Non-op | $-2M | $16M | $-2M | $8M | $8M | $13M | $-3M | $3M | $15M | $3M | $9M | $10M | $-3M | $6M | $7M | $6M | |
| Pretax Income | $416M | $412M | $334M | $330M | $328M | $384M | $276M | $299M | $296M | $314M | $266M | $237M | $299M | $317M | $277M | $109M | |
| Income Tax | $99M | $88M | $74M | $81M | $77M | $97M | $59M | $68M | $65M | $74M | $66M | $40M | $68M | $75M | $65M | $-4M | |
| Net Income | $312M | $320M | $252M | $245M | $245M | $282M | $220M | $222M | $226M | $229M | $194M | $192M | $225M | $235M | $202M | $101M | |
| EPS (Basic) | $2.82 | $2.88 | $2.27 | $2.21 | $2.18 | $2.51 | $1.97 | $1.98 | $2.01 | $2.05 | $1.74 | $1.72 | $1.99 | $2.08 | $1.80 | $0.93 | |
| EPS (Diluted) | $2.78 | $2.84 | $2.24 | $2.18 | $2.16 | $2.47 | $1.94 | $1.95 | $1.99 | $2.03 | $1.72 | $1.70 | $1.96 | $2.05 | $1.78 | $0.92 | |
| Shares (Basic) | 110,000,000 | 111,000,000 | 110,000,000 | · | 112,000,000 | 112,000,000 | 111,000,000 | · | 112,000,000 | 111,000,000 | 111,000,000 | · | 112,000,000 | 112,000,000 | 112,000,000 | · | |
| Shares (Diluted) | 112,000,000 | 112,000,000 | 112,000,000 | · | 113,000,000 | 113,000,000 | 113,000,000 | · | 113,000,000 | 112,000,000 | 112,000,000 | · | 114,000,000 | 114,000,000 | 113,000,000 | · | |
| EBITDA | $626M | $605M | $546M | · | $528M | $581M | $486M | · | $455M | $472M | $416M | · | $453M | $460M | $412M | · |
Neraca
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $797M | $626M | $393M | $420M | $432M | $319M | $188M | $549M | $764M | $271M | $474M | · | $143M | $126M | $175M | · | |
| Receivables | $1.71B | $1.67B | $1.59B | $1.41B | $1.46B | $1.42B | $1.40B | $1.30B | $1.38B | $1.32B | $1.32B | · | $1.28B | $1.24B | $1.25B | · | |
| Inventory | $218M | $233M | $225M | $189M | $186M | $187M | $189M | $188M | $184M | $182M | $181M | · | $184M | $184M | $190M | · | |
| Prepaid Expense | $390M | $319M | $361M | $361M | $333M | $273M | $294M | $351M | $299M | $245M | $251M | · | $207M | $188M | $195M | · | |
| Current Assets | $3.12B | $2.84B | $2.57B | $2.38B | $2.41B | $2.20B | $2.08B | $2.39B | $2.62B | $2.02B | $2.23B | · | $1.81B | $1.73B | $1.81B | · | |
| PP&E (Net) | $2.27B | $2.22B | $2.19B | $2.20B | $2.15B | $2.12B | $2.10B | $2.11B | $2.09B | $1.83B | $1.81B | · | $1.83B | $1.81B | $1.79B | · | |
| PP&E (Gross) | · | · | · | $6.18B | · | · | · | $5.77B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | · | $3.97B | · | · | · | $3.66B | · | · | · | · | · | · | · | · | |
| Goodwill | $9.11B | $9.11B | $9.12B | $8.95B | $8.90B | $8.88B | $8.85B | $8.86B | $8.61B | $7.88B | $7.83B | $7.73B | $7.73B | $7.73B | $7.24B | $7.22B | |
| Intangibles | $1.63B | $1.67B | $1.72B | $1.64B | $1.66B | $1.71B | $1.73B | $1.76B | $1.72B | $1.20B | $1.19B | · | $1.22B | $1.25B | $1.08B | · | |
| Other Non-current Assets | $274M | $277M | $256M | $270M | $296M | $271M | $260M | $255M | $272M | $216M | $182M | · | $149M | $152M | $150M | · | |
| Total Assets | $17.22B | $16.94B | $16.67B | $16.23B | $16.20B | $15.97B | $15.80B | $16.15B | $16.09B | $13.88B | $13.95B | · | $13.48B | $13.43B | $12.79B | · | |
| Accounts Payable | $1.64B | $1.60B | $1.50B | $1.60B | $1.46B | $1.35B | $1.27B | $1.39B | $1.31B | $1.25B | $1.24B | · | $1.16B | $1.20B | $1.20B | · | |
| Accrued Liabilities | · | · | · | $338M | · | · | · | $306M | · | · | · | · | · | · | · | · | |
| Current Liabilities | $1.83B | $1.79B | $2.18B | $2.28B | $2.13B | $2.02B | $1.44B | $2.17B | $2.09B | $2.01B | $2.30B | · | $1.62B | $1.88B | $1.35B | · | |
| Capital Leases | $554M | $561M | $574M | $537M | $534M | $540M | $538M | $535M | $543M | $507M | $489M | · | $505M | $508M | $490M | · | |
| Other Non-current Liabilities | $1.26B | $1.06B | $1.02B | $957M | $982M | $890M | $917M | $938M | $891M | $811M | $817M | · | $874M | $901M | $809M | · | |
| Long-term Debt | $5.55B | $5.64B | · | $5.67B | · | · | · | $6.22B | $6.25B | · | · | · | · | · | · | · | |
| Total Debt | $5.55B | $5.64B | $503M | · | $504M | $504M | $1M | · | $6.25B | $606M | $906M | · | $304M | $518M | $2M | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | |
| Retained Earnings | $10.59B | $10.37B | $10.15B | $9.99B | $9.84B | $9.68B | $9.49B | $9.36B | $9.22B | $9.08B | $8.94B | · | $8.71B | $8.57B | $8.41B | · | |
| Treasury Stock | $5.29B | $5.17B | $5.09B | $5.18B | $4.90B | $4.77B | $4.79B | $4.86B | $4.73B | $4.76B | $4.78B | · | $4.57B | $4.59B | $4.61B | · | |
| AOCI | $-66M | $-62M | $-43M | $-27M | $-40M | $-16M | $-83M | $-88M | $-15M | $-19M | $-16M | · | $-20M | $-16M | $-18M | · | |
| Stockholders' Equity | $7.63B | $7.52B | $7.37B | $7.17B | $7.26B | $7.23B | $6.93B | $6.78B | $6.81B | $6.62B | $6.43B | · | $6.42B | $6.25B | $6.05B | · | |
| Liabilities + Equity | $17.22B | $16.94B | $16.67B | $16.23B | $16.20B | $15.97B | $15.80B | $16.15B | $16.09B | $13.88B | $13.95B | · | $13.48B | $13.43B | $12.79B | · | |
| Shares Outstanding | 110,000,000 | 110,000,000 | 111,000,000 | 110,000,000 | 111,000,000 | 112,000,000 | 112,000,000 | 111,000,000 | 112,000,000 | 111,000,000 | 111,000,000 | 111,000,000 | 112,000,000 | 112,000,000 | 112,000,000 | 111,000,000 |
Arus Kas
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $147M | $146M | $147M | $145M | $142M | $143M | $140M | $135M | $125M | $117M | $116M | $109M | $111M | $112M | $107M | $116M | |
| Stock-based Comp | $20M | $23M | $20M | $25M | $20M | $21M | $22M | $27M | $19M | $20M | $22M | $19M | $18M | $16M | $24M | $22M | |
| Deferred Tax | $109M | $-2M | $48M | $-13M | $110M | $1M | $7M | $34M | $15M | $-18M | $-18M | $-10M | $-23M | $-12M | $-4M | $-44M | |
| Amort. of Intangibles | $37M | $38M | $37M | $37M | $39M | $39M | $39M | $37M | $32M | $29M | $29M | $27M | $27M | $28M | $26M | $39M | |
| Restructuring | · | · | · | · | $6M | $1M | · | · | $7M | $8M | · | · | $1M | $1M | · | · | |
| Other Non-cash | · | · | $-189M | · | · | · | $-75M | · | · | · | $-160M | · | · | · | $-235M | · | |
| Operating Cash Flow | $611M | $597M | $278M | $465M | $563M | $544M | $314M | $464M | $356M | $360M | $154M | $527M | $207M | $444M | $94M | $334M | |
| CapEx | $166M | $138M | $114M | $158M | $144M | $108M | $117M | $123M | $106M | $92M | $104M | $72M | $105M | $104M | $127M | $147M | |
| Investing Cash Flow | $-169M | $-134M | $-152M | $-191M | $-201M | $-124M | $-115M | $-502M | $-1.63B | $-200M | $-213M | $-114M | $-107M | $-682M | $-158M | $-174M | |
| Stock Repurchased | $150M | · | · | $300M | $150M | · | · | $151M | · | · | · | $275M | $0 | $0 | $0 | $461M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Dividends Paid | $95M | $96M | $88M | $90M | $89M | $90M | $84M | $84M | $84M | $84M | $79M | $80M | $80M | $80M | $74M | $75M | |
| Financing Cash Flow | $-271M | $-229M | $-152M | $-287M | $-247M | $-293M | $-561M | $-170M | $1.77B | $-363M | $-153M | $130M | $-83M | $189M | $-76M | $-545M | |
| Net Change in Cash | $171M | $233M | $-27M | $-12M | $113M | $131M | $-361M | $-215M | $493M | $-203M | $-212M | $543M | $17M | $-49M | $-140M | $-385M | |
| Free Cash Flow | · | · | $164M | · | · | · | $197M | · | · | · | $50M | · | · | · | $-33M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | $13M | · | · | · | $-61M | · |
Profitabilitas
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.5% | 15.1% | 13.8% | · | 13.7% | 15.9% | 13.1% | · | 13.3% | 14.8% | 12.7% | · | 14.9% | 14.9% | 13.1% | · | |
| Net Margin | 10.1% | 10.5% | 8.7% | · | 8.7% | 10.2% | 8.3% | · | 9.1% | 9.6% | 8.2% | · | 9.8% | 10.1% | 8.7% | · | |
| Pretax Margin | 13.4% | 13.5% | 11.5% | · | 11.7% | 13.9% | 10.4% | · | 11.9% | 13.1% | 11.2% | · | 13.0% | 13.6% | 11.9% | · | |
| EBITDA Margin | 20.2% | 19.9% | 18.9% | · | 18.8% | 21.0% | 18.3% | · | 18.3% | 19.7% | 17.6% | · | 19.7% | 19.7% | 17.7% | · | |
| ROA | 1.9% | 1.9% | 1.6% | · | 1.5% | 1.9% | 1.5% | · | 1.5% | 1.7% | 1.5% | · | 1.7% | 1.8% | 1.5% | · | |
| ROE | 4.2% | 4.3% | 3.5% | · | 3.5% | 4.1% | 3.3% | · | 3.4% | 3.6% | 3.1% | · | 3.5% | 3.7% | 3.2% | · | |
| ROIC | 2.8% | 2.7% | 4.0% | · | 3.8% | 4.2% | 3.9% | · | 2.0% | 3.8% | 3.1% | · | 3.9% | 3.9% | 3.9% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | 1.2 | · | 1.1 | 1.1 | 1.4 | · | 1.3 | 1.0 | 1.0 | · | 1.1 | 0.9 | 1.3 | · | |
| Quick Ratio | 1.4 | 1.3 | 0.9 | · | 0.9 | 0.9 | 1.1 | · | 1.0 | 0.8 | 0.8 | · | 0.9 | 0.7 | 1.1 | · | |
| Debt / Equity | 0.7 | 0.8 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.9 | 0.1 | 0.1 | · | 0.0 | 0.1 | 0.0 | · | |
| LT Debt / Equity | 0.7 | 0.7 | · | · | · | · | · | · | 0.8 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.6 | 6.1 | · | 8.3 | 8.9 | 8.2 | · |
Efisiensi
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | |
| Inventory Turnover | 10.2 | 9.6 | 9.4 | · | 10.1 | 9.9 | 9.7 | · | 9.1 | 8.7 | 8.6 | · | 8.4 | 8.3 | 8.1 | · | |
| Receivables Turnover | 2.0 | 2.0 | 1.9 | · | 2.0 | 2.0 | 1.9 | · | 1.9 | 1.9 | 1.8 | · | 1.8 | 1.8 | 1.8 | · |
Per Saham
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $69.38 | $68.33 | $66.36 | · | $65.39 | $64.54 | $61.87 | · | $60.79 | $59.61 | $57.95 | · | $57.37 | $55.79 | $54.02 | · | |
| Revenue / Share | $27.65 | $27.17 | $25.85 | · | $24.92 | $24.43 | $23.47 | · | $22.02 | $21.40 | $21.12 | · | $20.13 | $20.51 | $20.63 | · | |
| Cash Flow / Share | · | · | $2.48 | · | · | · | $2.78 | · | · | · | $1.38 | · | · | · | $0.83 | · | |
| Cash / Share | $7.25 | $5.69 | $3.54 | · | $3.89 | $2.85 | $1.68 | · | $6.82 | $2.44 | $4.27 | · | $1.28 | $1.12 | $1.56 | · | |
| Dividend / Share | $0.86 | $0.86 | $0.86 | $0.80 | $0.80 | $0.80 | $0.80 | $0.75 | $0.75 | $0.75 | $0.75 | $0.71 | $0.71 | $0.71 | $0.71 | $0.66 | |
| EPS (TTM) | $10.04 | $9.42 | $9.05 | · | $8.52 | $8.35 | $7.91 | · | $7.44 | $7.41 | $7.43 | · | $6.71 | $6.92 | $6.83 | · |
Valuasi (TTM)
| Metrik | Tren | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.84B | $11.56B | $11.28B | · | $10.85B | $10.52B | $10.16B | · | $9.54B | $9.35B | $9.29B | · | $9.30B | $9.49B | $9.60B | · | |
| Net Income TTM | $1.13B | $1.06B | $1.02B | · | $969M | $950M | $897M | · | $841M | $840M | $846M | · | $763M | $794M | $793M | · | |
| Market Cap | $25.64B | $23.31B | $21.75B | · | $21.15B | $20.12B | $18.95B | · | $17.39B | $15.19B | $14.78B | · | $13.65B | $15.74B | $15.85B | · | |
| Enterprise Value | $30.39B | $28.33B | $21.86B | · | $21.23B | $20.30B | $18.76B | · | $22.88B | $15.53B | $15.21B | · | $13.81B | $16.13B | $15.67B | · | |
| P/E | 23.2 | 22.5 | 21.7 | · | 22.4 | 21.5 | 21.4 | · | 20.9 | 18.5 | 17.9 | · | 18.2 | 20.3 | 20.7 | · | |
| P/S | 2.2 | 2.0 | 1.9 | · | 1.9 | 1.9 | 1.9 | · | 1.8 | 1.6 | 1.6 | · | 1.5 | 1.7 | 1.7 | · | |
| P/B | 3.4 | 3.1 | 3.0 | · | 2.9 | 2.8 | 2.7 | · | 2.6 | 2.3 | 2.3 | · | 2.1 | 2.5 | 2.6 | · | |
| P / Cash Flow | · | · | 78.3 | · | · | · | 60.4 | · | · | · | 95.9 | · | · | · | 168.6 | · | |
| EV / Revenue | 2.6 | 2.5 | 1.9 | · | 2.0 | 1.9 | 1.8 | · | 2.4 | 1.7 | 1.6 | · | 1.5 | 1.7 | 1.6 | · | |
| Dividend Yield | 1.4% | 1.6% | 1.6% | · | 1.6% | 1.7% | 1.8% | · | 1.9% | 2.1% | 2.2% | · | 2.3% | 1.9% | 1.9% | · | |
| Earnings Yield | 4.3% | 4.4% | 4.6% | · | 4.5% | 4.7% | 4.7% | · | 4.8% | 5.4% | 5.6% | · | 5.5% | 4.9% | 4.8% | · | |
| Payout Ratio | · | · | 34.9% | · | · | · | 38.2% | · | · | · | 40.7% | · | · | · | 36.6% | · | |
| Annual Payout | $369M | $363M | $357M | · | $347M | $342M | $336M | · | $327M | $323M | $319M | · | $309M | $307M | $305M | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $11.04B | $9.87B | $9.25B | $9.88B | $10.79B |
| Margin Operasi % | 14.1% | 13.6% | 13.6% | 14.4% | 22.1% |
| Laba Bersih | $992M | $871M | $854M | $946M | $2.00B |
| EPS Dilusian | $8.75 | $7.69 | $7.49 | $7.97 | $15.55 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.8 | 0.9 | 0.7 | 0.7 | 0.6 |
| Rasio Lancar | 1.0 | 1.1 | 1.3 | 1.2 | 1.6 |
| Rasio Cepat | 0.8 | 0.9 | 1.0 | 1.0 | 1.3 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $1.36B | $909M | $864M | $1.31B | $1.83B |
Pemilik institusional (13F) 1.173 pengaju · $23.2B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
1.173
Nilai yang dipegang
$23.2B
Posisi baru
118
Posisi yang keluar
65
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 118 (-22 vs Kuartal sebelumnya) | 65 (-17 vs Kuartal sebelumnya) | 431 (+89 vs Kuartal sebelumnya) | 346 (-23 vs Kuartal sebelumnya) | +3.8M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| VANGUARD GROUP INC | $2.497.458.052 | 14.392.082 | 10,75% | Saham |
| BlackRock, Inc. | $1.965.923.399 | 9.275.411 | 8,46% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.533.117.858 | 7.233.394 | 6,60% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.299.474.988 | 6.131.045 | 5,59% | Saham |
| STATE STREET CORP | $1.169.252.484 | 5.516.643 | 5,03% | Saham |
| Boston Partners | $1.004.552.880 | 4.744.473 | 4,32% | Saham |
| JPMORGAN CHASE & CO | $748.586.197 | 3.520.438 | 3,22% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $662.582.607 | 3.137.873 | 2,85% | Saham |
| MORGAN STANLEY | $521.503.271 | 2.460.497 | 2,24% | Saham |
| EdgePoint Investment Group Inc. | $476.372.038 | 2.247.568 | 2,05% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $421.376.156 | 1.988.048 | 1,81% | Saham |
| BANK OF AMERICA CORP /DE/ | $410.151.497 | 1.935.133 | 1,76% | Saham |
| Grantham, Mayo, Van Otterloo & Co. LLC | $400.206.122 | 1.888.207 | 1,72% | Saham |
| WELLS FARGO & COMPANY/MN | $371.171.119 | 1.751.220 | 1,60% | Saham |
| Davis Selected Advisers | $329.781.509 | 1.555.612 | 1,42% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $311.037.928 | 1.467.506 | 1,34% | Saham |
| NORGES BANK | $298.133.109 | 1.406.620 | 1,28% | Saham |
| FMR LLC | $296.462.102 | 1.398.735 | 1,28% | Saham |
| Invesco Ltd. | $292.303.423 | 1.379.115 | 1,26% | Saham |
| NORTHERN TRUST CORP | $238.963.873 | 1.127.454 | 1,03% | Saham |
| GOLDMAN SACHS GROUP INC | $208.282.052 | 982.694 | 0,90% | Saham |
| UBS Group AG | $188.403.627 | 888.906 | 0,81% | Saham |
| AMERICAN CENTURY COMPANIES INC | $173.422.135 | 818.220 | 0,75% | Saham |
| M&G PLC | $168.677.800 | 795.650 | 0,73% | Saham |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $165.917.256 | 846.603 | 0,71% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $163.988.047 | 773.711 | 0,71% | Saham |
| AMERIPRISE FINANCIAL INC | $161.076.730 | 759.975 | 0,69% | Saham |
| Legal & General Group Plc | $151.986.161 | 717.085 | 0,65% | Saham |
| Bank of New York Mellon Corp | $133.388.337 | 629.339 | 0,57% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $131.756.386 | 621.639 | 0,57% | Saham |
| DEUTSCHE BANK AG\ | $124.180.445 | 585.895 | 0,53% | Saham |
| ALLIANCEBERNSTEIN L.P. | $122.662.706 | 625.894 | 0,53% | Saham |
| Nuveen, LLC | $119.503.667 | 563.830 | 0,51% | Saham |
| PRINCIPAL FINANCIAL GROUP INC | $109.630.811 | 517.225 | 0,47% | Saham |
| RAYMOND JAMES FINANCIAL INC | $107.196.222 | 505.762 | 0,46% | Saham |
| Amundi | $105.710.274 | 498.751 | 0,45% | Saham |
| Woodline Partners LP | $102.974.000 | 485.841 | 0,44% | Saham |
| FIDUCIARY MANAGEMENT INC /WI/ | $102.489.906 | 483.557 | 0,44% | Saham |
| CRAWFORD INVESTMENT COUNSEL INC | $97.514.204 | 460.081 | 0,42% | Saham |
| BARCLAYS PLC | $95.107.474 | 448.726 | 0,41% | Saham |
| ENVESTNET ASSET MANAGEMENT INC | $90.834.224 | 428.564 | 0,39% | Saham |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $88.822.918 | 417.715 | 0,38% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $83.772.178 | 395.245 | 0,36% | Saham |
| Artemis Investment Management LLP | $77.981.726 | 334.585 | 0,34% | Saham |
| M.D. Sass, LLC | $76.397.960 | 360.453 | 0,33% | Saham |
| Qube Research & Technologies Ltd | $72.783.206 | 343.398 | 0,31% | Saham |
| MACKENZIE FINANCIAL CORP | $70.641.875 | 333.295 | 0,30% | Saham |
| Advisors Capital Management, LLC | $69.429.626 | 327.575 | 0,30% | Saham |
| CITIGROUP INC | $66.888.058 | 315.584 | 0,29% | Saham |
| Swiss National Bank | $65.683.305 | 309.900 | 0,28% | Saham |
Aktivis & pemilik 5%+ 13 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated | 18 Mei 2011 | · | Pengajuan awal | M&A / penjualan | SEC |
| Orang pelapor yang tidak diungkapkan | 1 Feb. 2011 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan | 20 Maret 2009 | · | Pengajuan awal | · | SEC |
| GlaxoSmithKline plc ×2 pengajuan | 18 Sep. 2008 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 16 Feb. 2007 | · | Pengajuan awal | · | SEC |
| Quest Diagnostics Incorporated - (FEIN No. ×2 pengajuan | 19 Jan. 2006 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 15 Des. 2004 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 29 Juni 2004 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 24 Juni 2002 | · | Pengajuan awal | M&A / penjualan | SEC |
| Orang pelapor yang tidak diungkapkan | 22 Mei 2002 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 12 April 2002 | · | Pengajuan awal | M&A / penjualan | SEC |
| IRS Identification Nos. of Above Persons (entities only) Quest Diagnostics Ventures LLC - (FEIN No., Quest Diagnostics Incorporated - (FEIN No. ×3 pengajuan | 1 Nov. 2001 | · | Pengajuan awal | M&A / penjualan | SEC |
| Orang pelapor yang tidak diungkapkan | 14 Mei 2001 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 52 orang dalam · 26 pejabat · 26 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| E. J. Davis | CEO and President | 1 Sep. 2026 S | 122.423 | 0 | 6 | $-17.083.502 |
| Surya N Mohapatra | Chairman, President & CEO | 30 April 2012 F | 243.713 | 0 | 0 | $0 |
| Sam Samad | Executive Vice President & CFO | 21 Okt. 2026 A | 33.568 | 0 | 0 | $0 |
| Mark Guinan | Executive Vice President & CFO | 7 Maret 2022 F | 98.981 | 0 | 0 | $0 |
| Robert Hagemann | SVP & Chief Financial Officer | 5 Maret 2013 F | 126.722 | 0 | 0 | $0 |
| Mark E Delaney | SVP & Chief Commercial Officer | 21 Okt. 2026 L | 10.360 | 0 | 2 | $-1.864.971 |
| Karthik Kuppusamy | SVP, Clinical Solutions | 21 Okt. 2026 L | 13.619 | 0 | 2 | $-2.167.772 |
| Patrick Plewman | SVP for Diagnostic Services | 21 Okt. 2026 L | 15.334 | 0 | 4 | $-2.025.174 |
| Michael E Prevoznik | SVP & General Counsel | 28 Agu 2026 M | 36.557 | 0 | 6 | $-6.649.682 |
| Catherine T. Doherty | EVP, Regional Businesses | 5 Maret 2026 S | 67.122 | 0 | 8 | $-6.964.749 |
| Michael J Deppe | SVP, Corp. Controller & CAO | 4 Maret 2026 F | 35.196 | 0 | 0 | $0 |
| Mark A Gardner | SVP of Molecular Gen & Oncol | 24 Sep. 2024 F | 4.673 | 0 | 0 | $0 |
| Manner Carrie Eglinton | SVP, Advanced Diagnostics | 7 Maret 2022 F | 48.391 | 0 | 0 | $0 |
| Manuel O. Mendez | SVP & Chief Commercial Officer | 17 Feb. 2021 A | 29.045 | 0 | 0 | $0 |
| Robert A Klug | VP, Corporate Controller | 1 Maret 2019 F | 6.261 | 0 | 0 | $0 |
| Jon R Cohen | SVP & Group Exec. Diag. Sol. | 8 Maret 2018 M | 31.757 | 0 | 0 | $0 |
| Everett Cunningham | SVP, Commercial | 1 Maret 2018 G | 37.760 | 0 | 0 | $0 |
| Thomas F Bongiorno | VP and Corporate Controller | 2 Maret 2015 F | 11.837 | 0 | 0 | $0 |
| John B. Haydon | SVP, Operations | 13 Feb. 2014 A | 19.890 | 0 | 0 | $0 |
| Kathy Ordonez | SVP, Diagnostic Solutions | 31 Maret 2013 F | 9.569 | 0 | 0 | $0 |
| Joan Elizabeth Miller | SVP-Oncology & Neurology Srvcs | 29 Feb. 2012 F | 89.232 | 0 | 0 | $0 |
| Wayne R. Simmons | Vice President, Operations | 16 Juni 2011 M | 47.150 | 0 | 0 | $0 |
| Robert E Peters | VP, Sales & Marketing | 12 Feb. 2007 A | 12.974 | 0 | 0 | $0 |
| David M Zewe | SVP, Diagnostic Testing Ops | 12 Feb. 2007 A | 31.079 | 0 | 0 | $0 |
| GRANT THOMAS W II | Sr VP, Ins. & Employer Serv. | 12 Feb. 2007 A | · | 0 | 0 | $0 |
| Gerald C Marrone | SVP, Administration | 28 Feb. 2004 F | 49.609 | 0 | 0 | $0 |
| Wright Lassiter III | Direktur | 21 Okt. 2026 L | 10.329 | 0 | 0 | $0 |
| Vicky B Gregg | Direktur | 21 Okt. 2026 A | 18.449 | 0 | 1 | $-239.700 |
| Robert B Carter | Direktur | 21 Okt. 2026 L | 3.874 | 0 | 0 | $0 |
| Timothy L Main | Direktur | 21 Okt. 2026 L | 22.478 | 0 | 0 | $0 |
| Timothy C Wentworth | Direktur | 1 Okt. 2026 A | 1.358 | 0 | 0 | $0 |
| Luis Diaz | Direktur | 20 Mei 2026 A | 5.196 | 0 | 0 | $0 |
| Tracey Doi | Direktur | 20 Mei 2026 A | 7.748 | 0 | 0 | $0 |
| Timothy M Ring | Direktur | 20 Mei 2026 A | 31.140 | 0 | 0 | $0 |
| Gary M Pfeiffer | Direktur | 20 Mei 2026 A | 31.005 | 0 | 0 | $0 |
| Gail R Wilensky | Direktur | 17 Mei 2023 A | 20.506 | 0 | 0 | $0 |
| Stephen H Rusckowski | Direktur | 6 Maret 2023 F | 389.597 | 0 | 0 | $0 |
| Helen Torley | Direktur | 25 Mei 2021 A | 6.260 | 0 | 0 | $0 |
| Daniel Stanzione | Direktur | 23 Nov. 2020 S | 28.349 | 0 | 0 | $0 |
| Jenne K Britell | Direktur | 4 Juni 2018 G | 14.479 | 0 | 0 | $0 |
| Jeffrey M Leiden | Direktur | 29 Mei 2018 S | 6.000 | 0 | 0 | $0 |
| John B Ziegler | Direktur | 22 Feb. 2017 S | 16.557 | 0 | 0 | $0 |
| John C Baldwin MD | Direktur | 12 Agu 2015 S | 12.949 | 0 | 0 | $0 |
| William F Buehler | Direktur | 12 Feb. 2014 M | 26.225 | 0 | 0 | $0 |
| GSK plc | Direktur | 31 Jan. 2011 S | 0 | 0 | 0 | $0 |
| Rosanne Haggerty | Direktur | 6 Mei 2010 A | 9.334 | 0 | 0 | $0 |
| William R Grant | Direktur | 1 April 2007 A | 3.334 | 0 | 0 | $0 |
| James F Flaherty III | Direktur | 4 Mei 2006 A | 1.667 | 0 | 0 | $0 |
| Kenneth D Brody | Direktur | 28 April 2004 S | 0 | 0 | 0 | $0 |
| Mary A Cirillo | Direktur | 1 April 2004 A | 2.627 | 0 | 0 | $0 |
| Denise M Morrison | · | 20 Mei 2026 A | 11.929 | 0 | 0 | $0 |
| FREEMAN KENNETH W/NJ | · | 14 Des. 2004 F | 216.187 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 143 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IHF · iShares Trust | 3,75% | 212.725 SH | 11 Sep. 2026 | Harian |
| RW · EA Series Trust | 2,50% | 1.865 NS | 31 Juli 2026 | N-PORT |
| BMVP · Invesco Exchange-Traded Fund Trust | 1,79% | 7.756 SH | 23 Okt. 2026 | Harian |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,57% | 62.536 SH | 23 Okt. 2026 | Harian |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,49% | 67.178 NS | 31 Juli 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 1,09% | 2.338 NS | 31 Juli 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 0,97% | 637 NS | 31 Juli 2026 | N-PORT |
| SPLV · Invesco Exchange-Traded Fund Trust … | 0,86% | 260.240 SH | 23 Okt. 2026 | Harian |
| SPVM · Invesco Exchange-Traded Fund Trust | 0,78% | 4.494 SH | 23 Okt. 2026 | Harian |
| JOET · Virtus ETF Trust II | 0,78% | 8.139 NS | 31 Juli 2026 | N-PORT |
| VUS · Virtus ETF Trust II | 0,73% | 560 NS | 31 Juli 2026 | N-PORT |
| ESMV · iShares Trust | 0,70% | 236 SH | 11 Sep. 2026 | Harian |
| QLV · FlexShares Trust | 0,63% | 4.452 NS | 31 Juli 2026 | N-PORT |
| HUSV · First Trust Exchange-Traded Fund III | 0,60% | 1.903 NS | 31 Juli 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 0,46% | 369.448 NS | 31 Juli 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,43% | 8.600 NS | 31 Juli 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,43% | 8.453 NS | 31 Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,41% | 64.629 SH | 11 Sep. 2026 | Harian |
| VOE · VANGUARD INDEX FUNDS | 0,40% | 711.079 SH | 19 Agu 2026 | Harian |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,38% | 22.688 NS | 31 Juli 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,37% | 52.313 NS | 31 Juli 2026 | N-PORT |
| IMCV · iShares Trust | 0,36% | 18.030 SH | 11 Sep. 2026 | Harian |
| DEUS · DBX ETF Trust | 0,34% | 4.285 NS | 31 Agu 2026 | N-PORT |
| SUSA · iShares Trust | 0,34% | 59.240 SH | 11 Sep. 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,34% | 330.273 SH | 19 Agu 2026 | Harian |
| IXJ · iShares Trust | 0,32% | 58.047 SH | 11 Sep. 2026 | Harian |
| DFLV · Dimensional ETF Trust | 0,30% | 87.905 NS | 31 Juli 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,30% | 19.944 NS | 31 Juli 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,30% | 2.178 NS | 31 Juli 2026 | N-PORT |
| EQIN · Columbia ETF Trust I | 0,27% | 3.540 NS | 31 Juli 2026 | N-PORT |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,26% | 9.337 NS | 31 Juli 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,26% | 27.542 NS | 31 Juli 2026 | N-PORT |
| IWS · iShares Trust | 0,25% | 165.299 SH | 11 Sep. 2026 | Harian |
| ESUM · Strategy Shares | 0,24% | 1.901 NS | 31 Juli 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,24% | 7.574.000 | 23 Okt. 2026 | Harian |
| SIZE · iShares Trust | 0,24% | 4.359 SH | 11 Sep. 2026 | Harian |
| VO · VANGUARD INDEX FUNDS | 0,23% | 2.398.948 SH | 19 Agu 2026 | Harian |
| VFMV · VANGUARD WELLINGTON FUND | 0,22% | 4.307 SH | 19 Agu 2026 | Harian |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 833.798 SH | 23 Okt. 2026 | Harian |
| ACWV · iShares, Inc. | 0,20% | 28.973 SH | 11 Sep. 2026 | Harian |
| EUSA · iShares, Inc. | 0,19% | 16.140 SH | 11 Sep. 2026 | Harian |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,19% | 1.371 NS | 31 Juli 2026 | N-PORT |
| IWR · iShares Trust | 0,19% | 452.857 SH | 11 Sep. 2026 | Harian |
| IMCB · iShares Trust | 0,18% | 12.959 SH | 11 Sep. 2026 | Harian |
| MTUM · iShares Trust | 0,16% | 168.369 SH | 11 Sep. 2026 | Harian |
| DFVX · Dimensional ETF Trust | 0,16% | 3.609 NS | 31 Juli 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,15% | 97.399 NS | 31 Juli 2026 | N-PORT |
| ESLG · Strategy Shares | 0,15% | 146 NS | 31 Juli 2026 | N-PORT |
| XOEF · iShares Trust | 0,15% | 140 SH | 11 Sep. 2026 | Harian |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0,13% | 117.237 SH | 23 Okt. 2026 | Harian |
| CATH · Global X Funds | 0,12% | 6.867 NS | 31 Juli 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,12% | 165.000 | 23 Okt. 2026 | Harian |
| ROUS · Lattice Strategies Trust | 0,12% | 3.633 NS | 31 Juli 2026 | N-PORT |
| EVUS · iShares Trust | 0,11% | 1.865 SH | 11 Sep. 2026 | Harian |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,10% | 625.384 SH | 19 Agu 2026 | Harian |
| VYM · VANGUARD WHITEHALL FUNDS | 0,10% | 440.583 SH | 19 Agu 2026 | Harian |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 3.259 SH | 23 Okt. 2026 | Harian |
| DGRO · iShares Trust | 0,10% | 179.879 SH | 11 Sep. 2026 | Harian |
| PFM · Invesco Exchange-Traded Fund Trust | 0,09% | 3.141 SH | 23 Okt. 2026 | Harian |
| SPXD · DBX ETF Trust | 0,09% | 27 NS | 31 Agu 2026 | N-PORT |
| APUE · Trust for Professional Managers | 0,09% | 9.352 NS | 31 Agu 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,09% | 1.051.572 SH | 19 Agu 2026 | Harian |
| DXUV · Dimensional ETF Trust | 0,09% | 2.092 NS | 31 Juli 2026 | N-PORT |
| CRBN · iShares Trust | 0,09% | 4.406 SH | 11 Sep. 2026 | Harian |
| DCOR · Dimensional ETF Trust | 0,09% | 12.279 NS | 31 Juli 2026 | N-PORT |
| IVE · iShares Trust | 0,09% | 183.297 SH | 11 Sep. 2026 | Harian |
| IUSV · iShares Trust | 0,08% | 97.344 SH | 11 Sep. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,08% | 167.227 NS | 31 Juli 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,08% | 25.423 SH | 19 Agu 2026 | Harian |
| MNZL · EA Series Trust | 0,08% | 87 NS | 31 Juli 2026 | N-PORT |
| CHRI · Global X Funds | 0,08% | 27 NS | 31 Juli 2026 | N-PORT |
| IQSU · New York Life Investments ETF Trust | 0,08% | 1.095 NS | 31 Juli 2026 | N-PORT |
| USSG · DBX ETF Trust | 0,08% | 1.887 NS | 31 Agu 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 3.185 SH | 23 Okt. 2026 | Harian |
| SUSL · iShares Trust | 0,08% | 3.907 SH | 11 Sep. 2026 | Harian |
| ILCV · iShares Trust | 0,07% | 4.337 SH | 11 Sep. 2026 | Harian |
| DSI · iShares Trust | 0,07% | 16.854 SH | 11 Sep. 2026 | Harian |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,07% | 66.643 SH | 19 Agu 2026 | Harian |
| IWD · iShares Trust | 0,07% | 245.078 SH | 11 Sep. 2026 | Harian |
| HLAL · Listed Funds Trust | 0,07% | 2.643 NS | 31 Agu 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,07% | 586 NS | 31 Juli 2026 | N-PORT |
| SNPE · DBX ETF Trust | 0,07% | 8.096 NS | 31 Agu 2026 | N-PORT |
| EGLE · Global X Funds | 0,06% | 6 NS | 31 Juli 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,06% | 3 NS | 31 Juli 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,06% | 24.937 SH | 23 Okt. 2026 | Harian |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,06% | 24.851 SH | 23 Okt. 2026 | Harian |
| DFSU · Dimensional ETF Trust | 0,05% | 5.056 NS | 31 Juli 2026 | N-PORT |
| QARP · DBX ETF Trust | 0,05% | 165 NS | 31 Agu 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,05% | 9.812 SH | 23 Okt. 2026 | Harian |
| DFAU · Dimensional ETF Trust | 0,05% | 26.447 NS | 31 Juli 2026 | N-PORT |
| TOPC · iShares Trust | 0,05% | 68 SH | 11 Sep. 2026 | Harian |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,05% | 3.309 SH | 23 Okt. 2026 | Harian |
| XVV · iShares Trust | 0,04% | 1.285 SH | 11 Sep. 2026 | Harian |
| XYLD · Global X Funds | 0,04% | 6.096 NS | 31 Juli 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,04% | 17.845 SH | 23 Okt. 2026 | Harian |
| PBP · Invesco Exchange-Traded Fund Trust | 0,04% | 662 SH | 23 Okt. 2026 | Harian |
| BKLC · BNY Mellon ETF Trust | 0,04% | 9.574 NS | 31 Juli 2026 | N-PORT |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 15.319 NS | 31 Juli 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,04% | 2.875.103 SH | 19 Agu 2026 | Harian |
| VV · VANGUARD INDEX FUNDS | 0,04% | 129.285 SH | 19 Agu 2026 | Harian |
| ESGV · VANGUARD WORLD FUND | 0,04% | 24.972 SH | 19 Agu 2026 | Harian |
| TOV · EA Series Trust | 0,04% | 426 NS | 31 Juli 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,04% | 5.593 NS | 31 Juli 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,04% | 1.876 NS | 31 Juli 2026 | N-PORT |
| XYLG · Global X Funds | 0,04% | 109 NS | 31 Juli 2026 | N-PORT |
| XCLR · Global X Funds | 0,04% | 6 NS | 31 Juli 2026 | N-PORT |
| IVV · iShares Trust | 0,04% | 1.392.389 SH | 11 Sep. 2026 | Harian |
| XTR · Global X Funds | 0,04% | 8 NS | 31 Juli 2026 | N-PORT |
| ILCB · iShares Trust | 0,04% | 2.144 SH | 11 Sep. 2026 | Harian |
| XRMI · Global X Funds | 0,04% | 82 NS | 31 Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,04% | 33.588 NS | 31 Juli 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,04% | 417 NS | 31 Juli 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,04% | 2.663 NS | 31 Juli 2026 | N-PORT |
| IWB · iShares Trust | 0,04% | 76.198 SH | 11 Sep. 2026 | Harian |
| VOXP · Advisors Series Trust | 0,04% | 9 NS | 31 Juli 2026 | N-PORT |
| IYY · iShares Trust | 0,04% | 4.688 SH | 11 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,03% | 30.298 SH | 11 Sep. 2026 | Harian |
| PHDG · Invesco Actively Managed Exchange-T… | 0,03% | 88 SH | 23 Okt. 2026 | Harian |
| ITOT · iShares Trust | 0,03% | 141.099 SH | 11 Sep. 2026 | Harian |
| KOKU · DBX ETF Trust | 0,03% | 1.098 NS | 31 Agu 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,03% | 772 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,03% | 3.515.122 SH | 19 Agu 2026 | Harian |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,03% | 18.213 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,03% | 9.300 SH | 19 Agu 2026 | Harian |
| SPXL · Direxion Shares ETF Trust | 0,03% | 8.650 NS | 31 Juli 2026 | N-PORT |
| URTH · iShares, Inc. | 0,03% | 10.177 SH | 11 Sep. 2026 | Harian |
| TILT · FlexShares Trust | 0,03% | 2.686 NS | 31 Juli 2026 | N-PORT |
| TOK · iShares Trust | 0,03% | 292 SH | 11 Sep. 2026 | Harian |
| ACWI · iShares Trust | 0,03% | 36.161 SH | 11 Sep. 2026 | Harian |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 95.097 SH | 19 Agu 2026 | Harian |
| DYNF · BlackRock ETF Trust | 0,02% | 34.844 SH | 11 Sep. 2026 | Harian |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 1.000 | 20 Okt. 2026 | Harian |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 Juli 2026 | Harian |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 Juli 2026 | Harian |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 Juli 2026 | Harian |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 Juli 2026 | Harian |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15 Juli 2026 | Harian |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Juli 2026 | Harian |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Juli 2026 | Harian |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 Juli 2026 | Harian |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Juli 2026 | Harian |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 Juli 2026 | Harian |
| VCEB · VANGUARD WORLD FUND | · | · | 30 Juli 2026 | Harian |
DGX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 23 analis
BELI
Target median
$260.00
+7,5%
6 26,1%
Beli Kuat
7 30,4%
Beli
10 43,5%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
15 analis · 2026-10-25Target rata-rata $254.73 +5,3%
Sekarang
Harga saat ini $241.89
Rendah$235.00
Rata-rata$254.73
Tinggi$275.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan
Sinyal langsung — satu-satunya kartu yang terisi di layar.
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Okt 23, 2026